Prognostic Impact of Systemic Coagulation-Inflammation Index in Acute Type A Aortic Dissection Surgery
- PMID: 36444319
- PMCID: PMC9700012
- DOI: 10.1016/j.jacasi.2022.06.007
Prognostic Impact of Systemic Coagulation-Inflammation Index in Acute Type A Aortic Dissection Surgery
Abstract
Background: A novel hematologic parameter, systemic coagulation-inflammation (SCI) index reflecting inflammation and coagulation pathways could be easily obtained from clinically routine laboratory findings. We hypothesize that the SCI index has prognostic implication in predicting operative mortality for patients with acute type A aortic dissection (ATAAD).
Objectives: This study aims to investigate the prognostic value of the SCI index and to establish an SCI-adding nomogram for mortality prediction in ATAAD patients.
Methods: A total of 1,967 ATAAD patients surgically repaired were collected from 12 Chinese cardiovascular centers by the 5A (Additive Anti-inflammatory Action for Aortopathy & Arteriopathy [Multicenter Retrospective Study]) study III (2016-2020). SCI index was calculated as platelet count × fibrinogen/white blood cell count on admission. By adding SCI index, a nomogram was developed and evaluated for 90-day mortality prediction with conventional predictors via the Cox model with 10-fold cross-validation.
Results: Patients were stratified with low SCI (<40), middle SCI (40-100), or high SCI (>100). The 90-day survival rates increased with SCI index (low 86.9%; [95% CI: 84.9%-89.0%], middle 92.7% [95% CI: 90.9%-94.9%], and high 96.4% [95% CI: 94.2%-98.6%]; log-rank P < 0.001). SCI index is independently associated with 90-day mortality (adjusted hazard ratio: 0.549; 95% CI: 0.424-0.710; P < 0.001). The addition of SCI index provided significantly incremental prognostic value to base model including age, serum creatinine, DeBakey class, and location of intimal entry (area under the curve: 0.677; 95% CI: 0.641-0.716 vs 0.724; 95% CI: 0.685-0.760; P = 0.002), which was confirmed by net reclassification improvement index (0.158; 95% CI: 0.065-0.235; P < 0.001) and integrated discrimination improvement index (0.070; 95% CI: 0.007-0.036; P < 0.001).
Conclusions: SCI index is easily obtainable, performs moderately well as a predictor of short-term mortality in ATAAD patients, and may be useful for risk stratification in emergency settings. (Additive Anti-inflammatory Action for Aortopathy & Arteriopathy [Multicenter Retrospective Study] III NCT04918108).
Keywords: ATAAD, acute type A aortic dissection; AUC, the area under the curve; DHCA, deep hypothermic circulatory arrest; SCI, systemic coagulation-inflammation index; SII, systemic immune-inflammation index; coagulation; inflammation; mortality; type A aortic dissection.
© 2022 The Authors.
Conflict of interest statement
This work was supported by the National Natural Science Foundation of China (82000305, 82070483), Scientific Research Common Program of Beijing Municipal Commission of Education (KM202110025014), and Beijing Municipal Science and Technology Commission (Z211100002921010). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures








Similar articles
-
Laboratory signatures differentiate the tolerance to hypothermic circulatory arrest in acute type A aortic dissection surgery.Interact Cardiovasc Thorac Surg. 2022 Nov 8;35(6):ivac267. doi: 10.1093/icvts/ivac267. Interact Cardiovasc Thorac Surg. 2022. PMID: 36271847 Free PMC article. Clinical Trial.
-
A Novel Inflammation-Based Risk Score Predicts Mortality in Acute Type A Aortic Dissection Surgery: The Additive Anti-inflammatory Action for Aortopathy and Arteriopathy Score.Mayo Clin Proc Innov Qual Outcomes. 2022 Sep 25;6(6):497-510. doi: 10.1016/j.mayocpiqo.2022.08.005. eCollection 2022 Dec. Mayo Clin Proc Innov Qual Outcomes. 2022. PMID: 36185465 Free PMC article.
-
Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.Front Oncol. 2022 Feb 28;12:829689. doi: 10.3389/fonc.2022.829689. eCollection 2022. Front Oncol. 2022. PMID: 35296020 Free PMC article.
-
Short- and Long-term survival prediction in patients with acute type A aortic dissection undergoing open surgery.J Cardiothorac Surg. 2024 Apr 2;19(1):171. doi: 10.1186/s13019-024-02687-x. J Cardiothorac Surg. 2024. PMID: 38566106 Free PMC article.
-
Operative Mortality After Type A Aortic Dissection Surgery: Differences Based on Sex and Age.JACC Adv. 2024 Mar 14;3(4):100909. doi: 10.1016/j.jacadv.2024.100909. eCollection 2024 Apr. JACC Adv. 2024. PMID: 38939657 Free PMC article.
Cited by
-
Inflammatory Trajectory and Anti-Inflammatory Pharmacotherapy in Frozen Elephant Trunk-Treated Acute Type I Aortic Dissection.J Soc Cardiovasc Angiogr Interv. 2024 Apr 5;3(7):101935. doi: 10.1016/j.jscai.2024.101935. eCollection 2024 Jul. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39132007 Free PMC article.
-
Inflammatory risk stratification individualizes anti-inflammatory pharmacotherapy for acute type A aortic dissection.Innovation (Camb). 2023 May 25;4(4):100448. doi: 10.1016/j.xinn.2023.100448. eCollection 2023 Jul 10. Innovation (Camb). 2023. PMID: 37333431 Free PMC article.
-
Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol.Future Cardiol. 2025 Jun;21(7):447-454. doi: 10.1080/14796678.2025.2505401. Epub 2025 May 14. Future Cardiol. 2025. PMID: 40367062 Clinical Trial.
-
Efficacy of hemadsorption combining with cardiopulmonary bypass used in patients with acute type A aortic dissection.J Cardiothorac Surg. 2025 Jun 24;20(1):269. doi: 10.1186/s13019-025-03497-5. J Cardiothorac Surg. 2025. PMID: 40556016 Free PMC article.
-
The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.Front Immunol. 2023 Jan 24;14:1082830. doi: 10.3389/fimmu.2023.1082830. eCollection 2023. Front Immunol. 2023. PMID: 36761773 Free PMC article.
References
-
- Erbel R., Aboyans V., Boileau C., et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC) Eur Heart J. 2014;35(41):2873–2926. - PubMed
-
- Bossone E., Eagle K.A. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol. 2021;18(5):331–348. - PubMed
-
- Morello F., Cavalot G., Giachino F., et al. White blood cell and platelet count as adjuncts to standard clinical evaluation for risk assessment in patients at low probability of acute aortic syndrome. Eur Heart J Acute Cardiovasc Care. 2017;6(5):389–395. - PubMed
-
- Zindovic I., Sjögren J., Bjursten H., et al. The coagulopathy of acute type A aortic dissection: a prospective, observational study. J Cardiothorac Vasc Anesth. 2019;33(10):2746–2754. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical